中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2013 No. 8

Display Method:
Editorial
Standardization of thermal ablation in treatment of liver tumor
Chen MinHua
2013, 29(8): 561-563. DOI: 10.3969/j.issn.1001-5256.2013.08.001
Abstract:

Thermal ablation ranks along with surgical resection and liver transplantation as a major radical treatment for liver tumor, and more and more attention has been paid to its efficacy and minimal invasiveness.However, the majority of Chinese patients who need ablation treatment have poor liver functi...

Discussions by experts
Prevention and treatment of major complications in liver cancer patients after thermal ablation
Jing Xiang, Chen MinHua
2013, 29(8): 564-566. DOI: 10.3969/j.issn.1001-5256.2013.08.002
Abstract:

Image-guided local thermal ablation plays an increasingly important role in the treatment of live cancer, and the safety of this therapy deserves some attention. The major complications of thermal ablation include bleeding, biliary complications, gastrointestinal perforation, infection, thoracic and...

Current situation on radiofrequency ablation of hepatic hemangioma
Zou Hua, Ma KuanSheng
2013, 29(8): 567-569. DOI: 10.3969/j.issn.1001-5256.2013.08.003
Abstract:

The recent progress in radiofrequency ablation (RFA) of hepatic hemangioma was reviewed, with a focus on radiofrequency electrodes, treatment modalities, complications, and prevention strategies.The foundation for the standardization of RFA of hepatic hemangioma was laid.The standardization of RFA w...

Role of contrast enhanced ultrasound in evaluating hepatic malignancies after ablation
Yan Kun
2013, 29(8): 570-572. DOI: 10.3969/j.issn.1001-5256.2013.08.004
Abstract:

Imaging evaluation of hepatic malignancies after ablation is an important clinical problem to be solved.Contrast enhanced ultrasound (CEUS) is a noninvasive, safe technique for acquiring the microcirculation information of treatment areas.The CEUS technique and the findings of local and distant recu...

Clinical significance of liver function evaluation before radiofrequency ablation in hepatocellular carcinoma
Wang Yu, Ou XiaoJuan, Wang XiaoMing, Jia JiDong
2013, 29(8): 573-575. DOI: 10.3969/j.issn.1001-5256.2013.08.005
Abstract:

Liver function is an important influential factor for the treatment outcome and prognosis of patients with hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA) and should be evaluated before operation. In order to demonstrate the clinical significance of liver function evaluation b...

Prognostic value of α-fetoprotein response in treatment of hepatocellular carcinoma
Jia Jia, Qi XingShun, Han GuoHong
2013, 29(8): 576-580. DOI: 10.3969/j.issn.1001-5256.2013.08.006
Abstract(3597) PDF (1194KB)(1018)
Abstract:

Primary hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver.Accurate assessment of treatment outcome and prognosis in HCC patients is very important due to its high malignancy and poor prognosis.Currently, radiological imaging, though a standard method for prognostic evalu...

Research progress in advanced oxidation protein products in liver diseases
Zhang Qian, Han Tao
2013, 29(8): 581-584. DOI: 10.3969/j.issn.1001-5256.2013.08.007
Abstract:

Advanced oxidation protein products (AOPP) are a class of oxidatively modified proteins closely associated with inflammation and oxidative stress. The progress in research on AOPP in liver diseases and discusses the source, biochemical characteristics, and biological effects of AOPP and its associat...

Original articles_Treatment of thermal ablation in liver tumor
Surgical resection versus radiofrequency ablation in treatment of small hepatocellular carcinoma
He XiuTing, Gao PuJun, Xu BaoDa, Hu XiaoXia
2013, 29(8): 585-587. DOI: 10.3969/j.issn.1001-5256.2013.08.008
Abstract:

Objective To compare clinical efficacy and recurrence between surgical resection and radiofrequency ablation (RFA) in the treatment of small hepatocellular carcinoma (HCC) .Methods The clinical data of 97 patients with small HCC, who underwent surgical resection or RFA as the initial treatment in Th...

Comparative study of radiofrequency ablation and percutaneous ethanol injection in treating postoperative recurrence of hepatocellular carcinoma
Zhang ZuoBing, Liu Jing, Fang Wei
2013, 29(8): 588-590. DOI: 10.3969/j.issn.1001-5256.2013.08.009
Abstract:

Objective To compare the clinical effects of radiofrequency ablation (RFA) and percutaneous ethanol injection (PEI) in treating postoperative recurrence of hepatocellular carcinoma (HCC) and to provide reference for clinical treatment of recurrent HCC. Methods A retrospective analysis was performed ...

Meta-analysis of transarterial chemoembolization combined with microwave coagulation therapy in treatment of advanced liver cancer
Zhou ZhenDong, Zhang LeMing, Wang TingTing, Sun XiaoKe, Chen LiangLiang, Liu Kui
2013, 29(8): 591-595. DOI: 10.3969/j.issn.1001-5256.2013.08.010
Abstract:

Objective To evaluate the clinical efficacy of transarterial chemoembolization (TACE) combined with microwave coagulation therapy (MCT) in the treatment of advanced liver cancer and to provide a more convincing basis for the clinical application of this therapy.Methods A search was performed using C...

Original articles_Viral hepatitis
Efficacy and safety of telbivudine in preventing mother-to-infant transmission of HBV in pregnant women with high HBV DNA load
Sun WeiHui, Chu LeiLei, Liu WeiLin, Hao AnHua, Ma Lei, Wan Qiang, Ren Rong, Xin YongNing
2013, 29(8): 596-599. DOI: 10.3969/j.issn.1001-5256.2013.08.011
Abstract:

Objective To evaluate the efficacy and safety of telbivudine given from the 12th week of gestation in preventing mother-to-infant transmission of hepatitis B virus (HBV) in pregnant women with high HBV DNA load.Methods Eighty pregnant women (at 12 weeks of gestation) with chronic hepatitis B, who ha...

Outcomes of nucleoside analogue-based salvage therapy in patients with multidrug-resistant chronic hepatitis B
Song MinNing, Huang WenQi, Min Feng
2013, 29(8): 600-602. DOI: 10.3969/j.issn.1001-5256.2013.08.012
Abstract:

Objective To investigate the efficacy of nucleoside analogue-based salvage therapy in patients with chronic hepatitis B (CHB) with multidrug resistance (MDR). Methods Twenty-seven CHB patients with MDR were divided into three equal groups for receipt of salvage therapy with: tenofovir (TDF) plus ent...

Therapeutic effect of antiviral therapy in chronic hepatitis B patients with nonalcoholic fatty liver disease
Ying RuoSu, Chen YanYu, Zhuo Li, Fan HuiMin, Yang Zhan
2013, 29(8): 603-606. DOI: 10.3969/j.issn.1001-5256.2013.08.013
Abstract:

Objective To retrospectively analyze the therapeutic effect of antiviral therapy in the chronic hepatitis B (CHB) patients with nonalcoholic fatty liver disease (NAFLD) and to investigate whether hepatocyte steatosis affects the response to antiviral therapy in CHB patients.Methods A total of 110 CH...

Roles of GCK mRNA and GLUT2 in abnormal glucose metabolism among patients with severe chronic hepatitis B
Zhang FenYan, Feng YanMei, Zhu YueKe, Zhang LiJie, Yu HongWei, Li Juan, Fu WanFa, Meng QingHua
2013, 29(8): 607-610. DOI: 10.3969/j.issn.1001-5256.2013.08.014
Abstract:

Objective To evaluate the expression of glucokinase (GCK) mRNA and glucose transporter-2 (GLUT2) in the liver tissues of patients with severe chronic hepatitis B and to preliminarily investigate their roles in abnormal glucose metabolism among patients with severe chronic hepatitis B.Methods The exp...

Original articles_Fatty liver
Experimental study on role of cannabinoid receptor 1 in non-alcoholic fatty liver disease among rats
Pan Jing, Yin YunQin, Zhang WenPing, Wang Dan
2013, 29(8): 611-615. DOI: 10.3969/j.issn.1001-5256.2013.08.015
Abstract:

Objective To observe the expression of endogenous cannabinoid receptor l (CB1) in rats with non-alcoholic fatty liver disease (NAFLD) and to preliminarily investigate the role of CB1 receptors in the pathogenesis of NAFLD. Methods Forty-eight male SD rats were randomly divided into three groups: con...

Original articles_Hepatopancreatobiliary tumor
Application of chemosensitivity test in regional chemotherapy for hepatocellular carcinoma via hepatic artery and portal vein
Nie Lei, Wu DongDe, Zhang Feng, Xia XiaoQin
2013, 29(8): 616-619. DOI: 10.3969/j.issn.1001-5256.2013.08.016
Abstract:

Objective To evaluate the chemosensitivities of hepatocellular carcinoma (HCC) to different chemotherapy drugs by 3- (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyl-2H tetrazolium bromide (MTT) assay and to provide guidance for individualized chemotherapy regimen in regional chemotherapy via the hepatic ...

Relationship between HBV infection and DNMT expression in liver cancer tissues
Zhang JiCai, Yu ZongTao, Lyu Jun, Li HaiPing, Gao Bo
2013, 29(8): 620-623. DOI: 10.3969/j.issn.1001-5256.2013.08.017
Abstract:

Objective To investigate the expression of DNA methyltransferases (DNMTs) in cancerous tissues, paracancerous tissues, and cirrhotic tissues among patients with liver cancer and to analyze the relationship between HBV infection and DNMT expression.Methods Forty-four samples were divided into HBV inf...

Significance of detection of multigene methylation in liver cancer tissue for early diagnosis of liver cancer
Li HaiPing, Gao Bo, Yu ZongTao, Liu JiuBo, Zhang JiCai
2013, 29(8): 624-626. DOI: 10.3969/j.issn.1001-5256.2013.08.018
Abstract:

Objective To evaluate the abnormal methylation of p14, p15, p16, and RB in the cancerous tissues of liver cancer patients and to investigate the significance of detection of multigene methylation for the early diagnosis of liver cancer. Methods Methylation-specific PCR was used to evaluate the methy...

Original articles_Others
Diagnostic value of serum cystatin C and urotensin II for hepatorenal syndrome in patients with decompensated liver cirrhosis
Zheng XiaoLi, Wang LiangZhi, He JianHua, Xiang XingChao, Zhou XiangYu
2013, 29(8): 627-630. DOI: 10.3969/j.issn.1001-5256.2013.08.019
Abstract:

Objective To evaluate the relation of serum cystatin C (CysC) and urotensin II (uII) levels with presence of hepatorenal syndrome in patients with decompensated liver cirrhosis to determine the diagnostic potential for these serum markers in order to facilitate early detection of hepatorenal syndrom...

Brief reports
Clinical effect of initial combination therapy with lamivudine plus adefovir dipivoxil in 48-week treatment of HBeAg-positive chronic hepatitis B
Ma YanHong
2013, 29(8): 631-632. DOI: 10.3969/j.issn.1001-5256.2013.08.020
Abstract:
Case reports
Case report of nonalcoholic fatty liver cirrhosis complicated with esophageal and gastric variceal bleeding
Liu YongFang, Jin ShanMei, Tian ZhenZhen, He FangHui, Gao RunPing
2013, 29(8): 633-634. DOI: 10.3969/j.issn.1001-5256.2013.08.021
Abstract:
Reviews
Research progress in methods for noninvasive diagnosis of nonalcoholic fatty liver disease
Bai Yang, Zhang Xia
2013, 29(8): 635-638. DOI: 10.3969/j.issn.1001-5256.2013.08.022
Abstract:

Liver biopsy (LB) is considered the gold standard for assessing the pathological damage of the liver in nonalcoholic fatty liver disease (NAFLD) , but this technique is not widely applied in clinical diagnosis because it is invasive.Rapid progress has been made in the research on the methods for non...

Research progress in role of RhoA in onset and development of hepatic fibrosis
Hong JinNi, An HaiYan
2013, 29(8): 639-641. DOI: 10.3969/j.issn.1001-5256.2013.08.023
Abstract:

The key step in the pathogenesis of hepatic fibrosis is the activation of hepatic stellate cells (HSCs) into fibroblasts and the abnormal expression of extracellular matrix (ECM) after activation.The important role of Rho/ROCK signaling pathway in the activation of HSCs is reviewed.It is summarized ...